Faeth Therapeutics, Inc. (FTH)
NASDAQ: FTH · Real-Time Price · USD
17.82
+1.17 (7.03%)
At close: Jun 18, 2026, 4:00 PM EDT
17.42
-0.40 (-2.24%)
After-hours: Jun 18, 2026, 7:44 PM EDT
Faeth Therapeutics Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
29
Market Cap
23.91M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | - | - | - |
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2010 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2008 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionFTH News
- 6 hours ago - Faeth Therapeutics files automatic mixed securities shelf - TheFly
- 3 days ago - Sensei Biotherapeutics Announces Name Change to Faeth Therapeutics, Focused on Advancing PIKTOR, an Oral Therapy Targeting One of the Most Frequently Altered Pathways in Cancer - Business Wire
- 14 days ago - Sensei Biotherapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
- 4 weeks ago - Sensei Biotherapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update - Business Wire
- 6 weeks ago - Sensei Biotherapeutics Doses First Patient in Phase 1b/2 Trial of PIKTOR in HR+/HER2- Advanced Breast Cancer - Business Wire
- 2 months ago - Sensei Biotherapeutics to Present at the 25th Annual Needham Virtual Healthcare Conference - Business Wire
- 2 months ago - Sensei Biotherapeutics Reports Full Year 2025 Financial Results and Provides Corporate Update - Business Wire
- 4 months ago - Sensei Biotherapeutics Announces Acquisition of Faeth Therapeutics and $200 Million Concurrent Private Placement - Business Wire